These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7995054)

  • 21. [Compared study on Fura-2/AM assay and MTT assay for screening multidrug resistant modulators].
    Fu LW; Pan QC; Lin GY
    Yao Xue Xue Bao; 1997 Jun; 32(6):401-5. PubMed ID: 11596320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histoculture drug response assay to monitor chemoresponse.
    Ohie S; Udagawa Y; Aoki D; Nozawa S
    Methods Mol Med; 2005; 110():79-86. PubMed ID: 15901929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
    Kirkpatrick DL; Duke M; Goh TS
    Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
    Sargent JM; Taylor CG
    Br J Cancer; 1989 Aug; 60(2):206-10. PubMed ID: 2765367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemosensitivity testing of an ovarian cancer cell line: comparison of MTT assay and [3H]-thymidine incorporation.
    Yu KJ; Ng HT; Chao KC; Chang CC; Kan YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):79-85. PubMed ID: 1848139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estimating doses of anti-cancer agents in sensitivity tests in vitro].
    Kobayashi K; Takemoto T; Hino M; Hayashihara K; Nakahiro K; Wasai S; Niitani H
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):399-403. PubMed ID: 1543368
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer.
    Xu JM; Song ST; Tang ZM; Liu XQ; Jiang ZF; Zhou L; Li YB; Huang Y
    Breast Cancer Res Treat; 1998 Jun; 49(3):251-9. PubMed ID: 9776509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay.
    Ganot N; Meker S; Reytman L; Tzubery A; Tshuva EY
    J Vis Exp; 2013 Nov; (81):e50767. PubMed ID: 24300943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of proliferation studies using the BrdU and MTT assays with a head and neck carcinoma cell line.
    Bergler W; Petroianu G; Schadel A
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(4):230-5. PubMed ID: 8336924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experience.
    Wu B; Zhu JS; Zhang Y; Shen WM; Zhang Q
    World J Gastroenterol; 2008 May; 14(19):3064-8. PubMed ID: 18494060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
    Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
    J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the extreme drug resistance assay to evaluate mechanisms of resistance in ovarian cancer: taxol resistance and MDR-1 expression.
    Fruehauf JP; Manetta A
    Contrib Gynecol Obstet; 1994; 19():39-52. PubMed ID: 7995052
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo/in vitro correlation of xenografts in nude mice and the ATP-cell viability assay.
    Perras JP; Hurst J
    Contrib Gynecol Obstet; 1994; 19():122-31. PubMed ID: 7995044
    [No Abstract]   [Full Text] [Related]  

  • 34. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH
    Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of predictability of in vitro SDI assay in comparison with in vivo nude mouse assay].
    Fujita M; Tanigawa K; Fujita F; Sakamoto Y; Shimozuma K; Kusuyama T; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3435-41. PubMed ID: 2802637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of Cytotoxicity.
    Prog Drug Res; 2016; 71():159-61. PubMed ID: 26939283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three cytotoxicity tests in the evaluation of the cytotoxicity of a spermine analogue on human breast cancer cell lines.
    Holst CM; Oredsson SM
    Toxicol In Vitro; 2005 Apr; 19(3):379-87. PubMed ID: 15713545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
    Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved MTT assay using the electron-coupling agent menadione.
    Garn H; Krause H; Enzmann V; Drössler K
    J Immunol Methods; 1994 Feb; 168(2):253-6. PubMed ID: 8308299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.